Allurion Technologies, Inc. ALUR recently announced the submission of the first three modules of its premarket approval application (PMA) to the FDA for the Allurion Balloon. Allurion capitalized on ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the submission of the first three modules of its premarket approval ...

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the publication of the first peer-reviewed study on the consecutive use of the Allurion Smart ...

The study included 1,143 patients with a body mass index (BMI) of ≥ 30 kg/m 2. "This study underscores the synergistic effects of the Allurion Smart Capsule with an individualized lifestyle ...

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced preliminary, unaudited results for the fourth quarter and full year 2025. Management expects ...

KUALA LUMPUR - The rising prevalence of overweight and obesity among adults in Malaysia is a growing concern, with statistics revealing that more than half of its adult population fall into these ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

Shantanu Gaur, MD, founded Allurion in 2009 while he was a student at Boston-based Harvard Medical School. Now, as CEO of the Natick, Mass.-based company, he’s leading efforts to redefine obesity care ...

Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the publication of a peer-reviewed, case-controlled study on the use of the Allurion Smart ...

The study included 121 overweight adults (BMI of 25 to 30) and adults with obesity (BMI of 30 and above) across 11 international sites. No serious device-related adverse events were reported. “This ...